Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients

Tyson GL, Kramer JR, Duan Z, Davila JA, Richardson PA, El-Serag HB. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2013;58(2):538-545.

Publication Type:

Journal Article

Authors:

Tyson, G.L.; Kramer, J.R.; Duan, Z.; Davila, J.A.; Richardson, P.A.; El-Serag, H.B.

Source:

Hepatology, Volume 58, Issue 2, p.538-545 (2013)

Keywords:

Adult, Anemia, blood, Blood Transfusion, Cocaine, Cohort Studies, coinfection, Dna, epidemiology, Female, Genotype, HCV, Health, Health Services, Health Services Research, Hepacivirus, hepatitis, Hepatitis B, Hepatitis B Virus, Hepatitis C, history, Hiv, Humans, Infection, Logistic Models, Male, microbiology, Middle Aged, Models,Statistical, pathogenicity, Patients, Prevalence, Registries, Research, Research Support, Retrospective Studies, Risk, Risk Factors, United States, United States Department of Veterans Affairs, Veterans

Notes:

PMC3729715

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/23505059

Export Citation:

RIS Format

Top